HitGen, Inc.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000040G3
CNY
30.78
0.04 (0.13%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

With a growth in Net Profit of 114.98%, the company declared Very Positive results in Sep 25

  • OPERATING CASH FLOW(Y) Highest at CNY 204.8 MM
  • ROCE(HY) Highest at 8.01%
  • PRE-TAX PROFIT(Q) At CNY 43.75 MM has Grown at 150.73%
2

Market Beating performance in long term as well as near term

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CNY 10,782 Million (Mid Cap)

stock-summary
P/E

77.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.22%

stock-summary
Debt Equity

-0.48

stock-summary
Return on Equity

9.11%

stock-summary
Price to Book

7.01

Revenue and Profits:
Net Sales:
161 Million
(Quarterly Results - Mar 2026)
Net Profit:
42 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
29.93%
0%
29.93%
6 Months
27.09%
0%
27.09%
1 Year
93.83%
0%
93.83%
2 Years
172.87%
0%
172.87%
3 Years
82.45%
0%
82.45%
4 Years
103.84%
0%
103.84%
5 Years
19.86%
0%
19.86%

HitGen, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
16.68%
EBIT Growth (5y)
27.97%
EBIT to Interest (avg)
5.08
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.56
Sales to Capital Employed (avg)
0.27
Tax Ratio
19.51%
Dividend Payout Ratio
47.57%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3.70%
ROE (avg)
4.35%

Valuation key factors

Factor
Value
P/E Ratio
77
Industry P/E
Price to Book Value
7.01
EV to EBIT
76.33
EV to EBITDA
57.90
EV to Capital Employed
12.62
EV to Sales
17.34
PEG Ratio
1.03
Dividend Yield
0.22%
ROCE (Latest)
16.54%
ROE (Latest)
9.11%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 50.42% vs -0.65% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 49.28% vs 100.00% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "160.50",
          "val2": "106.70",
          "chgp": "50.42%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "43.30",
          "val2": "36.80",
          "chgp": "17.66%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.70",
          "val2": "2.70",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.30",
          "val2": "-2.80",
          "chgp": "89.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "41.50",
          "val2": "27.80",
          "chgp": "49.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "269.70%",
          "val2": "190.70%",
          "chgp": "7.90%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 23.09% vs 16.19% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 120.64% vs 22.00% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "525.60",
          "val2": "427.00",
          "chgp": "23.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "166.90",
          "val2": "116.60",
          "chgp": "43.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "11.60",
          "val2": "13.10",
          "chgp": "-11.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-21.60",
          "val2": "-38.70",
          "chgp": "44.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "110.10",
          "val2": "49.90",
          "chgp": "120.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "206.60%",
          "val2": "142.40%",
          "chgp": "6.42%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoYstock-summary

Mar'26
Mar'25
Change(%)
Net Sales
160.50
106.70
50.42%
Operating Profit (PBDIT) excl Other Income
43.30
36.80
17.66%
Interest
2.70
2.70
Exceptional Items
-0.30
-2.80
89.29%
Consolidate Net Profit
41.50
27.80
49.28%
Operating Profit Margin (Excl OI)
269.70%
190.70%
7.90%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Mar 2026 is 50.42% vs -0.65% in Mar 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 49.28% vs 100.00% in Mar 2025

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
525.60
427.00
23.09%
Operating Profit (PBDIT) excl Other Income
166.90
116.60
43.14%
Interest
11.60
13.10
-11.45%
Exceptional Items
-21.60
-38.70
44.19%
Consolidate Net Profit
110.10
49.90
120.64%
Operating Profit Margin (Excl OI)
206.60%
142.40%
6.42%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 23.09% vs 16.19% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 120.64% vs 22.00% in Dec 2024

stock-summaryCompany CV
About HitGen, Inc. stock-summary
stock-summary
HitGen, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available